Fresenius Kabi (www.fresenius-kabi.us/lovo) is a leading global health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients. Through our recent acquisition of Fenwal, we bring over 60 years experience in cell collection, separation processing. Today, the team is focused on serving the needs of the Therapeutic Apheresis and Cellular Therapy communities. The gentle science design of the Fenwal Amicus platform brings precision MNC collection and therapeutic plasma exchange (TPE) to customers. Recently launched, Lovo is the only cell processing system that washes and concentrates white blood cells using filtration technology.